Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125815702 | 12581570 | 2 | F | 20140123 | 20160804 | 20160721 | 20160818 | EXP | US-ACORDA-ACO_126031_2016 | ACORDA | 64.96 | YR | F | Y | 0.00000 | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125815702 | 12581570 | 1 | PS | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | 1 | Unknown | UNK | Y | U | 20397 | ||||||||
| 125815702 | 12581570 | 2 | SS | NAPROSYN | NAPROXEN | 1 | Unknown | UNK | Y | U | 0 | ||||||||
| 125815702 | 12581570 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | Unknown | UNK | Y | U | 0 | ||||||||
| 125815702 | 12581570 | 4 | SS | PENNSAID | DICLOFENAC SODIUM | 1 | Topical | APPLY 2 PUMPS 40 MG TO THE AFFECTED KNEES BID | Y | U | 0 | 40 | MG | ||||||
| 125815702 | 12581570 | 5 | SS | Sulfa | UNSPECIFIED INGREDIENT | 1 | Unknown | UNK | Y | U | 0 | ||||||||
| 125815702 | 12581570 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, QD | U | 0 | 325 | MG | QD | ||||||
| 125815702 | 12581570 | 7 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | 1 TABLET, QD | U | 0 | QD | ||||||||
| 125815702 | 12581570 | 8 | C | Coq10 | UBIDECARENONE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 125815702 | 12581570 | 9 | C | DHEA | PRASTERONE | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | QD | ||||||
| 125815702 | 12581570 | 10 | C | ESTRADIOL. | ESTRADIOL | 1 | Oral | 1 MG, QD | U | 0 | 1 | MG | QD | ||||||
| 125815702 | 12581570 | 11 | C | FLECTOR | DICLOFENAC EPOLAMINE | 1 | Transdermal | APPLY 1 PATCH (180 MG) TO MOST PAINFUL AREA, QD | U | 0 | 180 | MG | TRANSDERMAL PATCH | QD | |||||
| 125815702 | 12581570 | 12 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 100 MG, TID | Y | U | 0 | 100 | MG | TID | |||||
| 125815702 | 12581570 | 13 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 125815702 | 12581570 | 14 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | QD | ||||||
| 125815702 | 12581570 | 15 | C | MUPIROCIN. | MUPIROCIN | 1 | Topical | USE AS DIRECTED 2% | U | 0 | OINTMENT | ||||||||
| 125815702 | 12581570 | 16 | C | OMEGA-3 ACIDS | OMEGA-3 FATTY ACIDS | 1 | Oral | 1000 MG, QD | U | 0 | 1000 | MG | QD | ||||||
| 125815702 | 12581570 | 17 | C | Oxycodone | OXYCODONE | 1 | Oral | 10 MG, Q 8 HRS | U | 0 | 10 | MG | Q8H | ||||||
| 125815702 | 12581570 | 18 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | U | 0 | 75 | MG | QD | ||||||
| 125815702 | 12581570 | 19 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125815702 | 12581570 | 1 | Product used for unknown indication |
| 125815702 | 12581570 | 2 | Product used for unknown indication |
| 125815702 | 12581570 | 3 | Product used for unknown indication |
| 125815702 | 12581570 | 4 | Product used for unknown indication |
| 125815702 | 12581570 | 5 | Product used for unknown indication |
| 125815702 | 12581570 | 6 | Product used for unknown indication |
| 125815702 | 12581570 | 7 | Product used for unknown indication |
| 125815702 | 12581570 | 8 | Product used for unknown indication |
| 125815702 | 12581570 | 9 | Product used for unknown indication |
| 125815702 | 12581570 | 10 | Product used for unknown indication |
| 125815702 | 12581570 | 11 | Product used for unknown indication |
| 125815702 | 12581570 | 12 | Product used for unknown indication |
| 125815702 | 12581570 | 13 | Product used for unknown indication |
| 125815702 | 12581570 | 14 | Product used for unknown indication |
| 125815702 | 12581570 | 15 | Product used for unknown indication |
| 125815702 | 12581570 | 16 | Product used for unknown indication |
| 125815702 | 12581570 | 17 | Product used for unknown indication |
| 125815702 | 12581570 | 18 | Anticoagulant therapy |
| 125815702 | 12581570 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125815702 | 12581570 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125815702 | 12581570 | Arthralgia | |
| 125815702 | 12581570 | Back pain | |
| 125815702 | 12581570 | Diabetes mellitus | |
| 125815702 | 12581570 | Drug hypersensitivity | |
| 125815702 | 12581570 | Lumbar radiculopathy | |
| 125815702 | 12581570 | Neuropathy peripheral | |
| 125815702 | 12581570 | Pain | |
| 125815702 | 12581570 | Pain in extremity | |
| 125815702 | 12581570 | Pruritus | |
| 125815702 | 12581570 | Rash | |
| 125815702 | 12581570 | Somnolence | |
| 125815702 | 12581570 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125815702 | 12581570 | 3 | 201602 | 201602 | 0 | |
| 125815702 | 12581570 | 11 | 20160407 | 0 | ||
| 125815702 | 12581570 | 12 | 20160219 | 0 | ||
| 125815702 | 12581570 | 17 | 20160531 | 0 |